10 Mar 2020 - 12 Mar 2020 | Lille, France
Hero Image
10 Mar 2020 - 12 Mar 2020
Lille, France
BIOKET 2020

WORKSHOP 2: IBISBA


The workshop will take place on the afternoon of March 12th 2020 (14h - 17h). You can assist to the workshop for free.
Registration to attend a worskshop is mandatory.


IBISBA within the global context of biofoundries and accelerated end-to-end bioprocess development

Download the full workshop description



IBISBA 1.0 – striving to facilitate end-to-end bioprocess development

Vision

IBISBA (www.ibisba.eu) is an emerging, European-based distributed R&D infrastructure that brings together best-in-class European R&D facilities, including biofoundries, creating a wider framework for accelerated end-to-end bioprocess development, the aim being to rapidly deliver industry-ready processes and thus reduce time to market.

In this session, we will appraise the current state of play in the bio foundry area and examine how biofoundries are likely to evolve in the future. We will focus on the IBISBA concept, looking at how biofoundry activities can be better developed within the wider framework of end-to-end bioprocess development, an approach that is being promoted by IBISBA. Moreover, we will examine some of the challenges related to injecting industry constraints into early phase bioprocess development.

This session will bring together leading researchers from the IBISBA network of research facilities, Prof. Paul Freemont (Imperial College London) who is heading the Global Foundry Alliance and industry players involved in the development of commercial biofoundries. The workshop will be a lively combination of talks and debates in which the audience will be invited to play a full, active role.


Draft programme: IBISBA within the global context of biofoundries and accelerated end-to-end bioprocess development

Chairpersonn: Dr Nic LINDKEY - CNRS France

14h00: Introduction - Dr Nic LINDLEY
14h10: Primer on biofoundries - Dr Paul FREEMONT, Imperial College London (United Kingdom)
14h40: An industrial biofoundry - Dr Sunil CHANDRAN, Amyris (USA)
15h00: IBISBA: a pan-European infrastructure to support industrial biotechnology - Dr Michael O'DONNOHUE, INRA (France)
15h10: IBISBA: driving IBISBA's biofoundry operations using knowledge management and integration - Pr Merja PENTTILA, VTT (Finland)
15h30: IBISBA: scaling-up or making industrial sense of biofoundry operations in IBISBA - Dr Gerd UNKELBACH, Fraunhofer CBP (Germany)
15h50: Coffee Break
16h10: Roundtable discussion: biofoundries in the wider biotech innovation picture - Dr Paul FREEMONT, Sunil CHANDRAN, Olivier ROLLAND (TWB), Gerd UNKELBACH, IBISBA representatives, GINKGO
16h50: Conclusions - Dr Nic LINDLEY


About IBISBA

IBISBA 1.0 is a H2020-funded project that aims at building a European distributed network of research facilities to provide innovation services and accelerate translation of bioscience research into industrial applications.

IBISBA 1.0 provides access to a specialised research facilities for all industrial biotechnology professionals, including academic researchers, SMEs and large companies.

The IBISBA 1.0 network also offers subsidised access through its Transnational Access (TNA) programme and will develop a variety of activities, such as training, that will benefit the wider scientific community.


Workshop organised in partnership with: